Sanofi
SNY
$45.80
Share price
-0.95%
Change (1 day)
-18.07%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
Sanofi (SNY) - Cash on Hand
Cash on Hand as of December 2023 : $9.92 B
According to Sanofi's latest financial reports the company has $9.92 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sanofi - Cash on Hand chart (from 2002 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $9.92 B | -30.82% |
| 2022-12-31 | $14.35 B | 13.63% |
| 2021-12-31 | $12.62 B | -7.93% |
| 2020-12-31 | $13.71 B | 24.27% |
| 2019-12-31 | $11.03 B | 35.43% |
| 2018-12-31 | $8.14 B | -34.67% |
| 2017-12-31 | $12.47 B | 15.01% |
| 2016-12-31 | $10.84 B | 8.29% |
| 2015-12-31 | $10.01 B | 12.05% |
| 2014-12-31 | $8.93 B | -22.16% |
| 2013-12-31 | $11.48 B | 34.88% |
| 2012-12-31 | $8.51 B | 57.97% |
| 2011-12-31 | $5.39 B | -37.54% |
| 2010-12-31 | $8.62 B | 21.22% |
| 2009-12-31 | $7.11 B | 10.01% |
| 2008-12-31 | $6.47 B | 147.05% |
| 2007-12-31 | $2.61 B | 57.07% |
| 2006-12-31 | $1.66 B | -9.46% |
| 2005-12-31 | $1.84 B | -45.38% |
| 2004-12-31 | $3.37 B | -20.57% |
| 2003-12-31 | $4.24 B | 28.89% |
| 2002-12-31 | $3.29 B | -27.94% |
| 2001-12-31 | $4.57 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 130.93% | 🇺🇸 USA |
 Novartis NVS | $13.96 B | 40.63% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 27.82% | 🇺🇸 USA |
 Novo Nordisk NVO | $4.47 B | -54.90% | 🇩🇰 Denmark |
 Abbott Laboratories ABT | $7.27 B | -26.68% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | -70.51% | 🇺🇸 USA |
 Merck MRK | $7.09 B | -28.56% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.28 B | 23.69% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | -35.99% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $3.22 B | -67.51% | 🇮🇱 Israel |